141 related articles for article (PubMed ID: 31987065)
21. Diagnosis and management of glycogen storage diseases type VI and IX: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG).
Kishnani PS; Goldstein J; Austin SL; Arn P; Bachrach B; Bali DS; Chung WK; El-Gharbawy A; Brown LM; Kahler S; Pendyal S; Ross KM; Tsilianidis L; Weinstein DA; Watson MS;
Genet Med; 2019 Apr; 21(4):772-789. PubMed ID: 30659246
[TBL] [Abstract][Full Text] [Related]
22. A novel 2.4-kb PHKA2 deletion in a boy with glycogen storage disease type IXa.
Sato T; Ichihashi Y; Sugie H; Ishii T; Hasegawa T
Congenit Anom (Kyoto); 2024 Mar; 64(2):63-65. PubMed ID: 38361096
[No Abstract] [Full Text] [Related]
23. Identification of a novel deletion mutation in PHKA2 in a taiwanese patient with type IXa glycogen storage disease.
Lin WD; Tsai FJ; Wang CH
Pediatr Neonatol; 2023 Jul; 64(4):465-467. PubMed ID: 37280121
[No Abstract] [Full Text] [Related]
24. Isolation of cDNA encoding the human liver phosphorylase kinase alpha subunit (PHKA2) and identification of a missense mutation of the PHKA2 gene in a family with liver phosphorylase kinase deficiency.
Hirono H; Hayasaka K; Sato W; Takahashi T; Takada G
Biochem Mol Biol Int; 1995 Jul; 36(3):505-11. PubMed ID: 7549948
[TBL] [Abstract][Full Text] [Related]
25. A novel PHKA2 variant in a Japanese boy with glycogen storage diseases type IXa.
Mori T; Ishikawa A; Shigetomi H; Fukuda T; Sugie H
Pediatr Int; 2022 Jan; 64(1):e14839. PubMed ID: 34837663
[No Abstract] [Full Text] [Related]
26. Glycogen storage disease type IX: novel PHKA2 missense mutation and cirrhosis.
Johnson AO; Goldstein JL; Bali D
J Pediatr Gastroenterol Nutr; 2012 Jul; 55(1):90-2. PubMed ID: 21857251
[No Abstract] [Full Text] [Related]
27. Profound neonatal lactic acidosis and renal tubulopathy in a patient with glycogen storage disease type IXɑ2 secondary to a
Morales JA; Tise CG; Narang A; Grimm PC; Enns GM; Lee CU
Mol Genet Metab Rep; 2021 Jun; 27():100765. PubMed ID: 34277355
[TBL] [Abstract][Full Text] [Related]
28. X-linked liver glycogenosis type II (XLG II) is caused by mutations in PHKA2, the gene encoding the liver alpha subunit of phosphorylase kinase.
Hendrickx J; Dams E; Coucke P; Lee P; Fernandes J; Willems PJ
Hum Mol Genet; 1996 May; 5(5):649-52. PubMed ID: 8733133
[TBL] [Abstract][Full Text] [Related]
29. Benign or not benign? Deep phenotyping of liver Glycogen Storage Disease IX.
Fernandes SA; Cooper GE; Gibson RA; Kishnani PS
Mol Genet Metab; 2020 Nov; 131(3):299-305. PubMed ID: 33317799
[TBL] [Abstract][Full Text] [Related]
30. Mutation hotspots in the PHKA2 gene in X-linked liver glycogenosis due to phosphorylase kinase deficiency with atypical activity in blood cells (XLG2).
Burwinkel B; Shin YS; Bakker HD; Deutsch J; Lozano MJ; Maire I; Kilimann MW
Hum Mol Genet; 1996 May; 5(5):653-8. PubMed ID: 8733134
[TBL] [Abstract][Full Text] [Related]
31. Novel PHKG2 mutation causing GSD IX with prominent liver disease: report of three cases and review of literature.
Albash B; Imtiaz F; Al-Zaidan H; Al-Manea H; Banemai M; Allam R; Al-Suheel A; Al-Owain M
Eur J Pediatr; 2014 May; 173(5):647-53. PubMed ID: 24326380
[TBL] [Abstract][Full Text] [Related]
32. Localization of a new type of X-linked liver glycogenosis to the chromosomal region Xp22 containing the liver alpha-subunit of phosphorylase kinase (PHKA2).
Hendrickx J; Coucke P; Hors-Cayla MC; Smit GP; Shin YS; Deutsch J; Smeitink J; Berger R; Lee P; Fernandes J
Genomics; 1994 Jun; 21(3):620-5. PubMed ID: 7959740
[TBL] [Abstract][Full Text] [Related]
33. Clinical, biochemical and molecular findings in a patient with X-linked liver glycogenosis followed for 40 years.
Hendrickx J; Bosshard NU; Willems P; Gitzelmann R
Eur J Pediatr; 1998 Nov; 157(11):919-23. PubMed ID: 9835437
[TBL] [Abstract][Full Text] [Related]
34. A novel PHKA1 mutation associating myopathy and cognitive impairment: Expanding the spectrum of phosphorylase kinase b (PhK) deficiency.
Bisciglia M; Froissart R; Bedat-Millet AL; Romero NB; Pettazzoni M; Hogrel JY; Petit FM; Stojkovic T
J Neurol Sci; 2021 May; 424():117391. PubMed ID: 33799212
[TBL] [Abstract][Full Text] [Related]
35. Novel mutations in PHKA2 gene in glycogen storage disease type IX patients from Hong Kong, China.
Lau CK; Hui J; Fong FN; To KF; Fok TF; Tang NL; Tsui SK
Mol Genet Metab; 2011 Feb; 102(2):222-5. PubMed ID: 21131218
[TBL] [Abstract][Full Text] [Related]
36. Liver glycogen storage diseases due to phosphorylase system deficiencies: diagnosis thanks to non invasive blood enzymatic and molecular studies.
Davit-Spraul A; Piraud M; Dobbelaere D; Valayannopoulos V; Labrune P; Habes D; Bernard O; Jacquemin E; Baussan C
Mol Genet Metab; 2011; 104(1-2):137-43. PubMed ID: 21646031
[TBL] [Abstract][Full Text] [Related]
37. PHKG2 mutation spectrum in glycogen storage disease type IXc: a case report and review of the literature.
Li C; Huang L; Tian L; Chen J; Li S; Yang Z
J Pediatr Endocrinol Metab; 2018 Mar; 31(3):331-338. PubMed ID: 29360628
[TBL] [Abstract][Full Text] [Related]
38. A novel PHKA2 gross deletion mutation in a Korean patient with X-linked liver glycogenosis type I.
Park KJ; Park HD; Lee SY; Ki CS; Choe YH
Ann Clin Lab Sci; 2011; 41(2):197-200. PubMed ID: 21844581
[TBL] [Abstract][Full Text] [Related]
39. Variability of clinical and biochemical phenotype in liver phosphorylase kinase deficiency with variants in the phosphorylase kinase (PHKG2) gene.
Waheed N; Saeed A; Ijaz S; Fayyaz Z; Anjum MN; Zahoor Y; Cheema HA
J Pediatr Endocrinol Metab; 2020 Sep; 33(9):1117-1123. PubMed ID: 32697758
[TBL] [Abstract][Full Text] [Related]
40. Genotypic and phenotypic features of 39 Chinese patients with glycogen storage diseases type I, VI, and IX.
Yu J; Ling X; Chen L; Fang Y; Lin H; Lou J; Ren Y; Chen J
Clin Genet; 2024 Apr; ():. PubMed ID: 38576397
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
